Navigation Links
Acceleron Pharma's ACE-031 Increases Muscle Mass and Strength in,Preclinical Studies

LUCCA, Italy--(BUSINESS WIRE)--May 14, 2007 - Acceleron Pharma, Inc., a biopharmaceutical company developing therapeutics for the treatment of musculoskeletal, metabolic and cancer-related diseases, today announced results of a preclinical study with ACE-031 that demonstrated the ability of the compound to increase muscle mass and strength in normal mice and in murine models of muscular dystrophy. ACE-031 inhibits negative regulators of muscle to increase muscle mass and strength as a potential treatment for neuromuscular diseases and cancer-related muscle loss. The data was presented on Sunday, May 13 at the Gordon Research Conference on Myogenesis in Lucca, Italy.

"Acceleron is encouraged by the significant outcomes and positive data generated by ACE-031 spanning numerous preclinical models of muscle loss", said Jas Seehra, Ph.D., Chief Scientific Officer of Acceleron. "ACE-031 and related Acceleron compounds consistently demonstrate substantial increases in skeletal muscle mass and strength."

ACE-031, a protein therapeutic based on the activin receptor type IIB (ActRIIB), is the first of several compounds Acceleron is developing for the treatment of diseases involving the loss of muscle mass, strength and function. ActRIIB binds to myostatin (GDF-8) and other negative regulators of muscle mass and strength. Over-expression of myostatin has been shown to cause a loss in muscle mass and strength, and inhibition of myostatin results in the selective increase in skeletal muscle mass and strength. In preclinical models, ACE-031 increased skeletal muscle mass and strength in disease models of amyotrophic lateral sclerosis (ALS), muscular dystrophy, glucocorticoid-induced muscle loss and age-related muscle loss (sarcopenia). ACE-031 offers the potential for an entirely new type of therapy for the treatment of various muscle wasting conditions.

"The clinical potential of ACE-031 to selectively increase
'"/>




Page: 1 2 3

Related medicine technology :

1. Accelreon Pharmas ACE-031Shown to Increase Muscle Mass in Preclinical Studies
2. Integrated BioPharmas Proprietary Vaccine Technology Achieves Strong Positive Results
3. Rapid HIV Testing Increases Possibility of Treatment
4. ProtoKinetixs AAGP Dramatically Increases Recovery Rate of Cryopreserved Stem Cells
5. MabThera Significantly Increases Survival of Lymphoma Patients Regardless of Chemotherapy Regimen
6. Researchers Discover a Common Variation in a Gene Segment that Increases the Risk for Prostate Cancer
7. New Data on Market-Leading Velcade (Bortezomib) for Injection Further Strengthen Role in Previously Treated Multiple Myeloma
8. SPIRIT Clinical Data Reaffirm Strength of Taxus and Promus Drug-Eluting Coronary Stent Systems
9. EntreMeds Aurora Kinase Inhibitor Induces Tumor Regression in Preclinical Models
10. Data Presented at AACR Meeting Shows Peregrines Immunocytokine Fusion Proteins Reduce Growth of B-Cell Lymphoma Tumors by 85% in Preclinical Studies
11. Data Presented at AACR Meeting Shows Bavituximab Equivalent Plus Docetaxel Reduces Growth of Both Hormone-Dependent and Hormone-Independent Prostate Cancer by Up to 94 Percent in Preclinical Studies
Post Your Comments:
(Date:5/23/2013)... SAINT PAUL, Minn. , May 23, 2013 /PRNewswire/ ... Angeion Corporation), a global medical technology company, today scheduled ... the second quarter of fiscal year 2013, ended April ... ET on Thursday, May 30, 2013. The Company will ... year 2013 after the markets close on Thursday, May ...
(Date:5/23/2013)... , May 23, 2013  Hadasit Bio-Holdings Ltd. ... of biotech companies, based on intellectual property developed ... Israel ,s foremost medical research center, today ... Ltd., received significant funding from the Israeli Ministry ... Scientist (OCS) to support product development and advance ...
(Date:5/23/2013)... SANTA MONICA, Calif. , May 23, 2013 /PRNewswire-USNewswire/ ... of a program that would have required them to ... announced today by Consumer Watchdog and Whatley Kallas LLC.  ... San Diego Superior Court, alleged that Blue Cross,s mandatory ... HIV/AIDS patients, threatening their health and privacy. ...
Breaking Medicine Technology:MGC Diagnostics Corporation to Report Second Quarter Fiscal 2013 Financial Results on Thursday, May 30, 2013 2Hadasit Bio-Holdings Ltd. Portfolio Company - Cell Cure Neurosciences Ltd. Received Additional Government Support 2Blue Cross To Allow HIV/AIDS Patients to "Opt-Out" of Mandatory Mail-Order Rx Drug Program, Announces Consumer Watchdog 2Blue Cross To Allow HIV/AIDS Patients to "Opt-Out" of Mandatory Mail-Order Rx Drug Program, Announces Consumer Watchdog 3
... March 16 SpineMark CRO Management, a wholly-owned ... recently signed an agreement with Ranier Technology, a ... provide contract research support services for the Ranier CAdisc™-L ... device for treatment of degenerative disc disease in the ...
... ) today announced that the company will hold its annual meeting of stockholders on Wednesday, June 9, 2010 at 9:00a.m. Pacific Time ... . , ... , , ... ...
Cached Medicine Technology:San Diego Based CRO Signs Agreement With UK Based Spinal Device Manufacturer 2San Diego Based CRO Signs Agreement With UK Based Spinal Device Manufacturer 3PDL BioPharma To Hold Annual Meeting of Stockholders on June 9, 2010 2
(Date:5/25/2013)... 25, 2013 The Slim Weight Patch has ... results. This is due to the highly sought after ingredients ... weight patch offers an extra 2 months supply & premium ... and get the body you desire faster than ever. , ... , With Slim weight patch consumers can observe instant ...
(Date:5/25/2013)... 2013 For college students, few ... Increasingly, they are turning to prescription stimulants like ... For more on this, go to http://www.sciencedaily.com/releases/2013/05/130501145151.htm ... warns that students who pick up Adderall, “just ... for developing a physical and psychological dependency. While ...
(Date:5/25/2013)... 25, 2013 Superior Magnetics for Pain ... in seconds for arthritis, tendinitis and bursitis , Pain ... relief products announced a magnetic bracelet so ... for pain relief is demonstrated at fairs and festivals. ... Gauss magnets and has customers often report pain relief ...
(Date:5/25/2013)... 25, 2013 http://www.resource4thepeople.com/defectivedrugs/Actos-Bladder-Cancer-Lawsuit.html , ... judge's overturning of a jury's award of $6.5 million ... trial* in the country over allegations that the diabetes ... files. , The judge in the case ruled that ... his cancer was caused by the medication.** , Bloomberg ...
(Date:5/24/2013)... FL (PRWEB) May 25, 2013 The ... Cellulite Whisperer ® products from Sublime Beauty®. The ... to diminish cellulite, and many of the ingredients are ... deal with and is dreaded by many women," says ... concentrated holistic plan, women can diminish their cellulite." The ...
Breaking Medicine News(10 mins):Health News:Slim Weight Patch Advanced Weight Loss System Offers Extra Two Month Supply and Membership for Maximum Weight Loss 2Health News:Addiction and Drug Abuse: Study Drug Adderall Abuse Spikes During Finals 2Health News:Magnetic bracelet relieves pain in seconds announces Superior Magnetics 2Health News:Alleged Actos Bladder Cancer Lawsuits Update: $6.5 Million Verdict Overturned as Resource4thePeople Attorneys Continue to Accept Cases 2Health News:Alleged Actos Bladder Cancer Lawsuits Update: $6.5 Million Verdict Overturned as Resource4thePeople Attorneys Continue to Accept Cases 3Health News:Alleged Actos Bladder Cancer Lawsuits Update: $6.5 Million Verdict Overturned as Resource4thePeople Attorneys Continue to Accept Cases 4Health News:"Get Ready for Summer Sale" at Sublime Beauty® Continues: New Cellulite Whisperer® Products 2
... Aug. 19 (HealthDay News) -- At 3 years of age, Pablo ... He also had frequent severe constipation, so much so that he ... of Alexandria, Va. Because of the prolapse, a condition in ... doctors worried that the boy, who is now 13, had cystic ...
... delicti is a plain flacon from among the possessions of ... exhibit in the permanent collection of the Egyptian Museum of ... the vessel may have held a deadly secret. This is ... Helmut Wiedenfeld from the university,s Pharmacology Institute just discovered. After ...
... (August 19, 2011) Antibiotics can help ward off serious ... catheters for their dialysis treatments. But if antibiotics are used ... to the drugs. A new randomized controlled clinical trial ... used to treat other serious infections may be a safe ...
... News) -- Cases of Legionnaire,s disease in the United States ... report shows. And while Legionnaires, disease is serious and ... for concern, most people recover with antibiotic treatment, officials said. ... Centers for Disease Control and Prevention rose from 1,110 in ...
... 18 (HealthDay News) -- Two gene variations that increase smokers, ... Smokers with the variants also tend to smoke more and ... Researchers at the Centre for Addiction and Mental Health in ... cancer and 443 current or former smokers without cancer. ...
... Society congratulates Dietrich Manzey, Maria Luz, Stefan Mueller, ... receiving the 2011 Human Factors Prize for their ... Assistance on Performance, Waorkload, Situation Awareness, and Acquisition ... is health-care ergonomics, broadly defined to include research ...
Cached Medicine News:Health News:Gluten-Free Set This Boy Free 2Health News:Deadly medication? 2Health News:Deadly medication? 3Health News:Acne-treating antibiotic cuts catheter infections in dialysis patients 2Health News:Cases of Legionnaire's Disease Tripled in 10 Years 2Health News:Gene Variants That Boost Lung Cancer Risk Identified 2Health News:Paper on automation in surgery wins 2011 Human Factors Prize for Excellence in HF/E Research 2Health News:Paper on automation in surgery wins 2011 Human Factors Prize for Excellence in HF/E Research 3Health News:Paper on automation in surgery wins 2011 Human Factors Prize for Excellence in HF/E Research 4
A One Piece Support Garment - any length or size...
Body Suit w/Bra torso, Front Closure...
Gynecomastia Vest...
Ideal for breast compression and contouring breast cups....
Medicine Products: